Archives of Biological Sciences 2011 Volume 63, Issue 3, Pages: 545-555
doi:10.2298/ABS1103545A
Full text ( 672 KB)
Cited by


Effects of Cyclamen trochopteranthum on hepatic drug-metabolizing enzymes

Arslan Sevki, Ozgun Ozden, Celik Gurbet, Semiz Asli, Dusen Olcay, Mammadov Ramazan, Sen Alaattin

The modulatory effects of the Cyclamen trochopterantum tuber extract on hepatic drug-metabolizing enzymes, including aniline 4-hydroxylase (A4H; CYP2E1), ethoxyresorufin O-deethylase (EROD; CYP1A), methoxyresorufin O-demethylase (MROD; CYP1A), caffeine N-demethylase (C3ND; CYP1A2) aminopyrene N-demethylase (APND; CYP2C6), and erythromycin N-demethylase (ERND; CYP3A1), were examined in vivo in rats. The activities of all of these enzymes were induced by the cyclamen extract. In addition, Western-blot and RT-PCR results clearly showed that CYP2E1, CYP1A1/CYP1A2 and CYP2C6 protein and mRNA levels were substantially increased by four different doses of cyclamen. Although, the CYP3A1 protein level was increased significantly, the mRNA level was not changed. These results indicate that cyclamen tuber extract might have a potential not only to inhibit and/or induce the metabolism of certain co-administered drugs but also influence the development of toxicity and carcinogenesis due to the induction of the cytochrome P450-dependent drug-metabolizing enzymes.

Keywords: Cyclamen trochopteranthum, drug-metabolizing enzymes, complementary and alternative herbs, drug interaction potential, cytochrome P450

More data about this article available through SCIndeks